These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3928815)

  • 1. Degradation of rat brain cholinergic muscarinic receptors in vitro: enhancement by agonists and inhibition by antagonists.
    Roskoski R; Guthrie R; Roskoski LM; Rossowski W
    J Neurochem; 1985 Oct; 45(4):1096-100. PubMed ID: 3928815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport.
    Zimmerman TW; Binder HJ
    Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptors and receptor-mediated actions on rat thymocytes.
    Maslinski W; Kullberg M; Nordström O; Bartfai T
    J Neuroimmunol; 1988 Mar; 17(4):265-74. PubMed ID: 3339119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential loss of [3H]pirenzepine vs [3H] (-) quinuclidinylbenzilate binding to soluble rat brain muscarinic receptors indicates that pirenzepine binds to an allosteric state of the muscarinic receptor.
    Roeske WR; Venter JC
    Biochem Biophys Res Commun; 1984 Feb; 118(3):950-7. PubMed ID: 6546685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
    Moret C; Pastrie I; Briley M
    Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinuclidinyl benzilate binding in house fly heads and rat brain.
    Jones SW; Sumikawa K
    J Neurochem; 1981 Feb; 36(2):454-9. PubMed ID: 7463072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methacholine-induced decrease in the cholinergic muscarinic receptor content in the perfused working rat heart.
    Reinhardt RR; Roskoski R
    J Pharmacol Exp Ther; 1983 Jul; 226(1):135-9. PubMed ID: 6345753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitative receptor autoradiography using [3H]-quinuclidinyl benzilate binding in the rat brain--a comparison with radio-receptor assay].
    Mori H; Shiba K; Matsuda H; Tsuji S; Hisada K
    Kaku Igaku; 1988 Jun; 25(6):533-41. PubMed ID: 3225962
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
    Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI
    J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of calcium antagonists on muscarinic receptor subtypes in the rat brain.
    Katayama S; Kito S; Miyoshi R; Matsubayashi H
    Brain Res; 1987 Sep; 422(1):168-71. PubMed ID: 3676778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic muscarinic receptors in rat myocardium: properties of [3H]quinuclidinyl benzilate [QNB] binding sites.
    Mittal CK
    Indian J Exp Biol; 1985 Jun; 23(6):300-5. PubMed ID: 4077129
    [No Abstract]   [Full Text] [Related]  

  • 16. Differences in affinities of muscarinic acetylcholine receptor antagonists for brain and heart receptors.
    Gibson RE; Rzeszotarski WJ; Eckelman WC; Jagoda EM; Weckstein DJ; Reba RC
    Biochem Pharmacol; 1983 Jun; 32(12):1851-6. PubMed ID: 6882462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine inhibits muscarinic cholinergic receptors in heart and brain.
    Sharkey J; Ritz MC; Schenden JA; Hanson RC; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1048-52. PubMed ID: 3047364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties and distribution of muscarinic cholinergic receptors in rat striatal micropunched tissue homogenates.
    Takano Y; Uchimura K; Kohjimoto Y; Kamiya H
    Eur J Pharmacol; 1981 Apr; 70(4):559-64. PubMed ID: 7238577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 125I-Labeled alpha-bungarotoxin and [3H]quinuclidinylbenzilate binding to rat brain membranes. Effects of physical, chemical and enzymatic treatments.
    Salvaterra PM
    Biochim Biophys Acta; 1980 Sep; 601(1):78-91. PubMed ID: 6773577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.